Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beckman bows out of Biosite bidding war as Inverness Medical Innovations muscles in

This article was originally published in Clinica

Executive Summary

Beckman Coulter has thrown in the towel in the fight for Biosite, announcing this week that it was not going to raise its $90 per share offer for the diagnostics manufacturer. The news comes days after rival Inverness Medical Innovations (IMI) sweetened its bid for Biosite from $90 to $92.50 per share.

Topics

UsernamePublicRestriction

Register

MT048395

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel